Understanding the BA.5 Variant: Challenges and Developments

This chapter delves into the BA.5 variant of COVID-19, identifying it as the dominant strain in the U.S. and noting its increased vaccine resistance and transmissibility. It discusses the implications of this variant on hospitalization rates, the effectiveness of existing boosters, and the evolving strategies for vaccination. The conversation highlights the complexities of immunity, emphasizing the need for a comprehensive approach to combat the ongoing pandemic.